RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new antibody discovery platform, Galaxy™, that offers significant advantages over the current generation of tools for delivery of new therapeutic monoclonal antibodies.
RxCelerate is a rapidly growing out-sourced drug development service provider, based on the Babraham Research Campus.
Building B280 Babraham Research Campus Babraham
Post Code: CB22 3AT
Country: United Kingdom
Membership Type: Corporate 21-50